Alcoa estimates, target cut at UBS
Shares of AA now seen reaching $13, according to UBS. Estimates also lowered as midstream expected to face seasonal lull. Neutral rating.
-----
American Electric estimates increased at Goldman
AEP estimates were raised through 2014, Goldman Sachs said. New rate settlement in Ohio is a positive. Neutral rating and $38 price target.
-----
Biogen upgraded at UBS
BIIB was upgraded from Neutral to Buy, UBS said. $113 price target. More comfortable with BG-12's CONFIRM.
-----
Best Buy estimates, target cut at Jefferies
Shares of BBY now seen reaching $25, according to Jefferies. Estimates also lowered as consumer spending looks set to slow. Hold rating.
-----
Best Buy estimates lowered at JP Morgan
BBY estimates were cut through 2013, JP Morgan said. Company has low near-term sales visibility. Neutral rating and $30 price target.
-----
Carter's upgraded at Sterne Agee
CRI was upgraded from Neutral to Buy, Sterne Agee said. $38 price target. Gross margins should begin to recover from higher cotton costs.
-----
Cisco Systems upgraded at RBC
CSCO was upgraded from Underperform to Sector Perform, RBC Capital said. $17 price target. Worst may be behind the company.
-----
Corning estimates, target cut at Goldman
GLW estimates were reduced through 2013, Goldman Sachs said. Company lowered its guidance. Neutral rating and new $16 price target.
-----
Corning estimates, target cut at UBS
Shares of GLW now seen reaching $20, according to UBS. Estimates also cut on lower guidance on display and gorilla glass.
-----
Covidien estimates, target reduced at Goldman
Shares of COV now seen reaching $59, according to Goldman Sachs. Company is seeing lower sales and rising operating costs. Buy rating.
-----
HealthSpring estimates raised at UBS
HS estimates increased through 2012, UBS said. M&A pipeline remains active despite CareMore/Arcadian transactions. Maintain $52 price target and Buy rating.
-----
Joy Global estimates lowered at KeyBanc
JOYG estimates lowered through 2013, KeyBanc said. Ongoing concerns about global growth. Maintain Hold rating.
-----
Lab Corp. of America estimates upped at Credit Suisse
LH estimates were boosted through 2013, Credit Suisse said. Company extended its agreement with UNH. Neutral rating and $102 price target.
-----
Las Vegas Sands numbers raised at JP Morgan
Shares of LVS now seen reaching $59, according to JP Morgan. Estimates also increased, as Asia continues to drive growth. Overweight rating.
-----
Lazard downgraded at Ticonderoga
LAZ was downgraded from Buy to Neutral, Ticonderoga Securities said. Debt concerns could push out a recovery in M&A activity.
-----
Mohawk Industries numbers reduced at Credit Suisse
Shares of MHK now seen reaching $47, according to Credit Suisse. Estimates also cut, as the company delayed price increases. Neutral rating.
-----
ProLogic rated new Hold at KeyBanc
PLD was initiated with a Hold rating, KeyBanc said. Merger integration risk.
-----
Research in Motion downgraded at Jefferies
RIMM was downgraded from Hold to Underperform, Jefferies said. $25 price target. Lackluster sell-through, competition, and valuation.
-----
Research in Motion target increased at UBS
RIMM price target increased to $32, UBS said. BB& roll out should help near term trends. Neutral rating.
-----
RPM International upgraded at Credit Suisse
RPM was upgraded to Neutral from Underperform, Credit Suisse said. Valuation call, based on a $24 price target.
-----
Smithfield Foods numbers cut at Credit Suisse
SFD estimates were lowered through 2014, Credit Suisse said. Hog production margins are slowing. Neutral rating and new $23 price target.
-----
Sunoco upgraded at Goldman
SUN was upgraded from Sell to Neutral, Goldman Sachs said. $47 price target. Exiting the refinery business increases the company's sum-of-the-parts value.
-----
Tesoro downgraded at Goldman
TSO was downgraded to Sell, Goldman Sachs said. $22 price target. Company is leveraged to falling West Coast
refining margins.
-----
Texas Instruments estimates cut at Credit Suisse
TXN estimates were reduced through 2012, Credit Suisse said. Company is seeing lower sales. Outperform rating and $40 price target.
-----
Texas Instruments estimates, target lowered at UBS
Shares of TXN now seen reaching $28, according to UBS. Estimates also cut on lower company outlook for the September quarter.
-----
Waters target lowered at UBS
WAT price target cut to $87, UBS said. Multiple compression on the group reduces upside potential. Neutral rating.
